Meeder Asset Management Inc. Has $1.99 Million Stake in Dolby Laboratories $DLB

Meeder Asset Management Inc. increased its position in shares of Dolby Laboratories (NYSE:DLBFree Report) by 787.1% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 27,526 shares of the electronics maker’s stock after purchasing an additional 24,423 shares during the quarter. Meeder Asset Management Inc.’s holdings in Dolby Laboratories were worth $1,992,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Boothbay Fund Management LLC grew its holdings in Dolby Laboratories by 4.1% in the 2nd quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after buying an additional 157 shares in the last quarter. Mitchell & Pahl Private Wealth LLC grew its stake in shares of Dolby Laboratories by 1.1% in the third quarter. Mitchell & Pahl Private Wealth LLC now owns 15,733 shares of the electronics maker’s stock valued at $1,139,000 after acquiring an additional 170 shares in the last quarter. Equitable Trust Co. increased its position in Dolby Laboratories by 3.3% during the second quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker’s stock worth $413,000 after acquiring an additional 177 shares during the period. Steward Partners Investment Advisory LLC raised its stake in Dolby Laboratories by 13.9% in the 2nd quarter. Steward Partners Investment Advisory LLC now owns 1,587 shares of the electronics maker’s stock worth $118,000 after purchasing an additional 194 shares in the last quarter. Finally, State of Michigan Retirement System boosted its holdings in Dolby Laboratories by 1.4% in the 2nd quarter. State of Michigan Retirement System now owns 14,800 shares of the electronics maker’s stock valued at $1,099,000 after purchasing an additional 200 shares during the period. 58.56% of the stock is currently owned by institutional investors.

Dolby Laboratories Trading Up 1.2%

Shares of Dolby Laboratories stock opened at $64.37 on Monday. The firm’s 50 day moving average is $65.95 and its 200 day moving average is $70.11. The firm has a market capitalization of $6.15 billion, a PE ratio of 24.48 and a beta of 0.88. Dolby Laboratories has a 1 year low of $63.05 and a 1 year high of $89.66.

Dolby Laboratories (NYSE:DLBGet Free Report) last issued its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating the consensus estimate of $0.70 by $0.29. The business had revenue of $307.02 million during the quarter, compared to the consensus estimate of $305.76 million. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The firm’s revenue was up .7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, research analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd were issued a dividend of $0.36 per share. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Tuesday, December 2nd. This represents a $1.44 annualized dividend and a dividend yield of 2.2%. Dolby Laboratories’s dividend payout ratio (DPR) is 54.75%.

Insider Transactions at Dolby Laboratories

In other Dolby Laboratories news, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $65.55, for a total value of $196,650.00. Following the completion of the transaction, the senior vice president owned 67,435 shares of the company’s stock, valued at $4,420,364.25. This represents a 4.26% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Kevin J. Yeaman sold 6,751 shares of the stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $67.24, for a total value of $453,937.24. Following the completion of the transaction, the chief executive officer owned 98,377 shares of the company’s stock, valued at $6,614,869.48. This represents a 6.42% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 162,120 shares of company stock worth $10,906,559. 37.93% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

DLB has been the topic of several recent research reports. Barrington Research lowered their target price on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a report on Wednesday, November 19th. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Monday, January 5th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday, December 29th. Finally, Rosenblatt Securities cut their target price on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Wednesday, November 19th. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $92.00.

View Our Latest Research Report on DLB

About Dolby Laboratories

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Further Reading

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.